|
| Thursday, May 13, 2021 |
|
|
Shineway (2877.HK) Q1 revenue increased by 37.0% |
| China Shineway Pharmaceutical Group Limited (2877.HK) recently released its unaudited turnover for the three months ended 31 March 2021 (Q1 2021) based on its management accounts. more info >> |
|
|
President Xi Jinping reiterates the country's support for Traditional Chinese Medicine |
| During his visit to Henan Province Nanyang City yesterday, President Xi Jinping commented on the necessity to further develop Traditional Chinese Medicine, to interpret the principles of Traditional Chinese Medicine utilising modern science, and adopt a path on integrating Traditional Chinese medicine and Western drugs on clinical treatments. more info >> |
|
| Tuesday, December 1, 2020 |
|
|
China Shineway Pharmaceutical records 29.4% revenue growth in October |
| China Shineway Pharmaceutical (stock code: 2877.HK) recorded 29.4% revenue growth for October 2020 in comparison with the same period last year, as sales of injection products, soft capsule products, granule products, TCM formula granules, and other dosage forms rose. more info >> |
|
| Monday, November 30, 2020 |
|
|
神威药业 (02877.HK) 十月份单月营业额比去年同期录得29.4%增长 |
| 神威药业（股份代號：02877.HK）於二零二零年十月份单月营业额比去年同期录得29.4%增长，其中注射液产品、软胶囊产品、颗粒剂产品、中药配方颗粒、及其他剂型产品营业额分别上升了38.9%， 17.4%，38.1%，7.9%，及 54.0% 。 more info >> |
|
|
神威藥業 (02877.HK) 十月份單月營業額比去年同期錄得29.4%增長 |
| 神威藥業（股份代號：02877-HK）於二零二零年十月份單月營業額比去年同期錄得29.4%增長，其中注射液產品、軟膠囊產品、顆粒劑產品、中藥配方顆粒、及其他劑型產品營業額分別上升了38.9%， 17.4%，38.1%，7.9%，及 54.0% 。 more info >> |
|
|
Shineway Pharmaceutical (2877.HK) recorded 29.4% revenue growth for October 2020 |
| Shineway Pharmaceutical (stock code: 2877.HK) recorded 29.4% revenue growth for October 2020 in comparison with the same period last year. more info >> |
|
|
|
|
